CA Patent

CA2845108C — 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections

Assigned to Wockhardt Ltd · Expires 2015-06-16 · 11y expired

What this patent protects

Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.

USPTO Abstract

Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number: CA2845108C
Jurisdiction: CA
Classification: —
Expires: 2015-06-16
Drug substance claim: No
Drug product claim: No
Assignee: Wockhardt Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.